State Of Wyoming Uni Qure N.V. Transaction History

State Of Wyoming

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$13.15 - $20.45 $4,444 - $6,912	-338 Reduced 12.94%	2,275 $42,000
Q1 2022 May 13, 2022	BUY	$14.54 - $21.5 $21,490 - $31,777	1,478 Added 130.22%	2,613 $47,000
Q4 2021 Feb 11, 2022	BUY	$20.24 - $36.01 $21,211 - $37,738	1,048 Added 1204.6%	1,135 $24,000
Q2 2021 Feb 11, 2022	SELL	$29.97 - $37.17 $1,138 - $1,412	-38 Reduced 30.4%	87 $3,000
Q1 2021 Feb 08, 2022	BUY	$29.24 - $42.03 $3,655 - $5,253	125 New	125 $4,000

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.